First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
May/June 2024 Kontos Kommentary The following commentary is produced by Tom Kontos, Chief Economist, ADESA Auctions.
Join Tom Kerr as he interviews Nikki Wilson, Senior Director of Clinical Pharmacy Services to dive deeper into part
For over three decades, early intervention telephoni
Work-related injuries involving limb or other losses are rare but tragic for any individual and require sensitive care coordination.
Join Tom Kerr as he interviews Nikki Wilson, Senior Director of Clinical Pharmacy Services to dig into part one of our Annua